During the past decade, Clinical Research Institute conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Institute" #1 sponsor was "NLS Pharmaceutics" with 2 trials, followed by "Allergan" with 1 trials sponsored, "Avadel" with 1 trials sponsored, "Engage Therapeutics, Inc." with 1 trials sponsored and "Forest Laboratories" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

According to Clinical.Site data, the most researched conditions in "Clinical Research Institute" are "Narcolepsy" (5 trials), "Excessive Daytime Sleepiness" (2 trials), "Major Depressive Disorder" (2 trials), "Cataplexy" (1 trials) and "Cataplexy Narcolepsy" (1 trials). Many other conditions were trialed in "Clinical Research Institute" in a lesser frequency.

Most popular intervention types in "Clinical Research Institute" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Fluoxetine" (2 trials), "Daridorexant 10 mg" (1 trials), "Daridorexant 25 mg" (1 trials) and "Daridorexant 50 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Institute" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Research Institute". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Clinical Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Institute, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".